NewAmsterdam Pharma Company N.V. NAMS

Healthcare — Biotechnology

Insider Buys (last 12m)

Insider Buys alert about insiders buying in the last 12 month

Overview Business Profile Analyst Commentary Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

	Dec '25	Dec '24	Dec '23	Dec '22	Jan '22	Dec '21	Jan '21	Dec '20	Jan '20	Dec '17
Cash and Short Term Investments	637.56	834.19	340.45	467.73	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Receivables	—	4.95	—	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—	—
Other current assets	—	—	—	—	‡‡‡‡‡	—	‡‡‡‡‡	—	‡‡‡‡‡	—
Total current assets	675.70	863.41	346.79	477.98	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Property, Plant, Equpment (Net)	0.38	0.24	0.05	0.03	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—	—	—
Long-Term Investments	92.61	—	—	—	—	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Long-term receivables	—	—	—	—	—	‡‡‡‡‡	—	—	—	—
Goodwill and Intangible Assets (Total)	0.41	0.53	0.17	0.21	‡‡‡‡‡	—	—	—	—	—
Long-term assets (Other)	—	—	0.04	0.16	‡‡‡‡‡	—	—	—	‡‡‡‡‡	—
Total non-current assets	93.58	1.21	0.31	0.52	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—
Total Assets	769.28	864.62	347.10	478.50	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡
Accounts Payable	8.97	4.74	16.92	11.85	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Accrued Expenses	15.42	13.61	11.40	6.12	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—
Current Part of Debt	—	—	—	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—	—
Current Revenue (Deferred)	3.99	6.01	8.94	13.87	—	—	—	—	—	—
Other current liabilities	57.27	82.31	12.57	4.15	‡‡‡‡‡	—	‡‡‡‡‡	—	‡‡‡‡‡	—
Total current liabilities	85.79	106.92	49.90	36.06	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Long Term Debt (Total)	—	—	—	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—	—
Non-current Revenue (Deferred)	—	—	1.02	4.79	‡‡‡‡‡	‡‡‡‡‡	—	‡‡‡‡‡	—	—
Non-current Liabilities (Other)	—	—	7.79	7.52	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Total non-current liabilities	0.07	0.20	8.81	12.37	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—
Total liabilities	85.85	107.12	58.70	48.43	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Additional Paid In Capital	1,426.75	1,298.16	590.77	555.63	—	—	—	‡‡‡	—	—
Common Stock (Net)	14.28	13.44	10.17	10.06	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Retained Earnings	(762.39)	(558.57)	(316.97)	(140.04)	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Shareholders Equity (Other)	—	—	—	4.94	—	‡‡‡‡‡	—	—	—	—
Common Equity (Total)	683.43	757.50	288.39	430.07	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Shareholders Equity (Total)	683.43	757.50	288.39	430.07	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Shareholders Equity and Liabilities (Total)	769.28	864.62	347.10	478.50	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—
Shares (Common)	114.40	108.06	82.47	81.56	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—
Shareholders Equity (Tangible)	683.02	756.97	288.22	429.86	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—
Net Debt	(637.56)	(834.19)	(340.45)	(467.73)	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	‡‡‡‡‡	—
Total Debt	—	—	—	—	‡‡‡‡‡	—	‡‡‡‡‡	—	—	—

Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Subscribe now